Research Use Only. The information presented here is for scientific and educational purposes. These compounds are not intended for human consumption, self-administration, or therapeutic use.
Introduction
The melanocortin system is one of the most subtype-diverse receptor families in mammalian biology, and the research peptides most often studied through it, Melanotan-1 (MT-1), Melanotan-2 (MT-2), and PT-141, are distinguished less by chemistry than by which of the five receptor subtypes they engage. A search for melanotan 2 usually leads to questions about melanogenesis, but the deeper story is the receptor map: five G-protein-coupled receptors named MC1R through MC5R, each expressed in different tissues and studied for a different physiological role. Understanding that map is the key to reading any melanocortin peptide correctly.
This primer describes the five melanocortin receptor subtypes, focuses on the three (MC1R, MC3R, and MC4R) most relevant to peptide research, and maps MT-1, MT-2, and PT-141 onto them by their reported receptor preferences and molecular attributes. It stays entirely within melanocortin-receptor pharmacology, the only framework in which these compounds are described here. All of it is for research use only, not for human consumption, and reflects receptor biology and preclinical models rather than any applied use.
The Melanocortin Receptor Family: Five Subtypes
The melanocortin receptors are class A G-protein-coupled receptors that signal primarily through Gs and the elevation of cyclic AMP. Their endogenous ligands are the melanocortin peptides derived from proopiomelanocortin (POMC), chiefly the alpha, beta, and gamma forms of melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone (ACTH), balanced by the endogenous antagonists agouti and agouti-related protein (AgRP). What makes the family distinctive is that a single peptide hormone class is read differently by five receptors in five tissue contexts. The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Subtype | Principal tissue localization | Main endogenous ligand | Studied physiological role |
|---|---|---|---|
| MC1R | Melanocytes (skin, hair follicle) | alpha-MSH | Melanogenesis and pigment type switching |
| MC2R | Adrenal cortex | ACTH (only) | Steroidogenesis; requires the MRAP1 accessory protein |
| MC3R | Hypothalamus, limbic system | alpha- and gamma-MSH | Energy homeostasis and feeding rhythm research |
| MC4R | Hypothalamus (paraventricular nucleus) | alpha-MSH | Central energy balance and food-intake signaling |
| MC5R | Exocrine glands | alpha-MSH | Exocrine and sebaceous gland research in animal models |
Two subtypes sit apart from peptide-agonist research. MC2R responds only to ACTH, not to the MSH peptides, and requires the melanocortin receptor accessory protein MRAP1 to reach the cell surface, a mechanism detailed in a 2023 structural study of human MC2R and MRAP1. MC5R is studied mostly in exocrine-gland models. The three subtypes that dominate melanocortin peptide research, and the rest of this article, are MC1R, MC3R, and MC4R.
MC1R, MC3R, and MC4R: The Research-Relevant Subtypes
MC1R and pigmentation
MC1R is the melanocyte receptor. When alpha-MSH binds it, rising cyclic AMP drives the microphthalmia-associated transcription factor (MITF) program and shifts pigment synthesis from red-yellow pheomelanin toward brown-black eumelanin. A 2021 structural study of the human MC1R described a calcium-mediated mode of hormone recognition, an unusual feature in which a divalent cation participates directly in ligand binding. MC1R is the subtype most associated with melanogenesis research and is the primary reason melanocortin analogs are studied as tools in pigment biology.
MC3R and MC4R in the central nervous system
MC3R and MC4R are the central melanocortin receptors, concentrated in the hypothalamus and studied for their role in energy homeostasis. MC4R in the paraventricular nucleus is the more intensively characterized of the two: it is a long-standing model receptor for the study of central food-intake signaling, reviewed comprehensively as early as a 2010 Endocrine Reviews survey of MC4R physiology and pharmacology and revisited in a 2016 account of MC4R-regulated energy homeostasis. MC3R contributes a complementary role in feeding rhythm and energy partitioning. For melanocortin peptides that reach the central nervous system in research models, these two receptors are the relevant targets, and a compound’s balance between them is a central experimental variable.
Melanotan 2, Melanotan 1, and PT-141 Across the Receptors
The three peptides most studied through the melanocortin system differ in structure and in how broadly they engage the receptor subtypes. Mapping each onto the receptors clarifies why they are used for different research questions. The values below reflect commonly reported laboratory attributes and are provided for comparison only.
| Research peptide | Structure | Approx. MW | Reported receptor preference | Primary research context |
|---|---|---|---|---|
| Melanotan-1 (MT-1) | Linear 13-residue alpha-MSH analog ([Nle4, D-Phe7]) | ~1646 Da | Broad melanocortin agonist, studied at MC1R for pigment work | Melanogenesis research |
| Melanotan-2 (MT-2) | Cyclic 7-residue lactam analog | ~1024 Da | Broad agonist across MC1R, MC3R, MC4R, MC5R | Melanogenesis and broad melanocortin signaling |
| PT-141 | Cyclic 7-residue analog (free-acid derivative of MT-2) | ~1025 Da | MC3R and MC4R preferring melanocortin agonist | Central melanocortin (MC3R/MC4R) signaling research |
Melanotan-1
Melanotan-1 is the linear analog [Nle4, D-Phe7]-alpha-MSH, a modification of the natural hormone that resists enzymatic breakdown and extends its research half-life. Because it retains the full 13-residue framework, it is studied primarily as an MC1R-directed tool in pigment biology.
Melanotan-2
Melanotan-2 is a cyclic heptapeptide analog, more compact and metabolically stable than MT-1, and reported to act as a broad agonist across MC1R, MC3R, MC4R, and MC5R. That wide receptor coverage is why melanotan 2 appears in a range of melanocortin research contexts rather than a single one, and why it is often the reference compound in comparative subtype assays.
PT-141
PT-141 is a close structural relative of MT-2, differing at the C-terminus (a free-acid derivative), which shifts its reported preference toward the central MC3R and MC4R subtypes. In research it is described strictly as a central melanocortin-receptor agonist, and its interest lies in probing MC4R signaling in preclinical models. It is studied only within that receptor-pharmacology framework.
Structural Biology of Melanocortin Receptor Activation
The past few years have produced a near-complete structural picture of the family. Cryo-electron microscopy studies published in 2021 resolved active-state MC4R in complex with the Gs protein bound to the synthetic agonist NDP-alpha-MSH and to a small-molecule melanocortin agonist, revealing how ligands sit in a deep, wide orthosteric pocket characteristic of these receptors. Companion 2021 work solved MC1R with its calcium-assisted binding mode, and a 2023 study extended the set to MC3R and MC5R, describing the residues that account for subtype selectivity. A 2024 report added a receptor-specific nanobody agonist of MC4R, illustrating how selectively the pocket can be addressed.
The practical message from this structural work is that the melanocortin subtypes share a conserved activation core but differ in the outer pocket, which is exactly where subtype-selective ligands gain or lose preference. It is the structural basis for the receptor-preference differences summarized above, and it explains why small changes to a cyclic heptapeptide, as between MT-2 and PT-141, can shift the balance across subtypes. These insights come from purified receptors and cell systems and describe molecular recognition, not any physiological application.
Evaluating Research-Grade Melanocortin Peptides
Because the melanocortin peptides are studied for their receptor-subtype behavior, identity and purity matter for reproducible receptor assays. A cyclic peptide such as MT-2 or PT-141 should be confirmed by mass spectrometry and HPLC, and the reported molecular weights above provide a quick identity check against a certificate of analysis. Researchers new to interpreting these documents can consult the COA reading guide, and lot-specific certificates allow a stated structure to be checked against the actual material.
These peptides are supplied as lyophilized powders for laboratory use and are research use only, not for human consumption. The three sit alongside one another in the melanocortin section of the research peptide catalog, where their differing receptor preferences make them a natural comparator set for subtype-focused work.
Frequently Asked Questions
What are the melanocortin receptor subtypes?
There are five: MC1R (melanocytes, pigmentation), MC2R (adrenal cortex, ACTH-only, steroidogenesis), MC3R and MC4R (hypothalamus, energy homeostasis), and MC5R (exocrine glands). They are Gs-coupled G-protein-coupled receptors activated by melanocortin peptides derived from proopiomelanocortin.
Which receptors does melanotan 2 act on?
Melanotan-2 is reported as a broad melanocortin agonist active across MC1R, MC3R, MC4R, and MC5R. Its wide receptor coverage, combined with the metabolic stability of its cyclic heptapeptide structure, is why it is frequently used as a reference compound in comparative melanocortin subtype research.
How does melanotan 1 differ from melanotan 2?
Melanotan-1 is a linear 13-residue analog of alpha-MSH studied mainly as an MC1R-directed tool in pigment biology, with a molecular weight near 1646 Da. Melanotan-2 is a smaller cyclic 7-residue analog near 1024 Da with broader receptor coverage. The two differ in size, structure, and receptor breadth.
What is the difference between PT-141 and Melanotan-2?
PT-141 is a close structural relative of Melanotan-2, differing at the C-terminus as a free-acid derivative. That change shifts its reported preference toward the central MC3R and MC4R subtypes, so it is studied specifically as a central melanocortin-receptor agonist rather than as a broad melanogenesis tool.
Which melanocortin receptor is most studied for energy homeostasis?
MC4R, concentrated in the hypothalamic paraventricular nucleus, is the most intensively studied melanocortin receptor for central energy-balance and food-intake signaling. MC3R contributes a complementary role. Both have been resolved structurally, and both are the relevant targets for centrally acting melanocortin research peptides.
Are melanocortin research peptides intended for human use?
No. Melanotan-1, Melanotan-2, and PT-141 are supplied for research use only, not for human consumption or self-administration. They are described here strictly within melanocortin-receptor pharmacology, based on receptor biology and preclinical models.
References and Further Reading
- Structures of active melanocortin-4 receptor and Gs-protein complexes with NDP-alpha-MSH and a small-molecule agonist (Cell Research, 2021). PubMed: active melanocortin-4 receptor Gs complex NDP-alpha-MSH structure
- Structural mechanism of calcium-mediated hormone recognition by the human melanocortin-1 receptor (Cell Research, 2021). PubMed: calcium-mediated hormone recognition melanocortin-1 receptor structure
- Structural insights into ligand recognition and subtype selectivity of the human MC3R and MC5R (Cell Discovery, 2023). PubMed: melanocortin-3 melanocortin-5 receptor subtype selectivity structure
- Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1 (Cell Research, 2023). PubMed: melanocortin-2 receptor MRAP1 structure
- A melanocortin-4 receptor specific orthosteric nanobody agonist (Nature Communications, 2024). PubMed: melanocortin-4 receptor nanobody agonist structure
- Tao YX and colleagues on melanocortin-4 receptor physiology, pharmacology, and pathophysiology (Endocrine Reviews, 2010). PubMed: melanocortin-4 receptor physiology pharmacology pathophysiology
- Reviews of MC4R-regulated energy homeostasis and central melanocortin signaling. PubMed: melanocortin-4 receptor regulated energy homeostasis
